The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.


Updates from The Motley Fool

Latest updates on AtriCure from Fool.com.


Stock Performance

ATRC vs. S&P 500 | 2 Year Performance
View Interactive ATRC Charts
Sponsored by

Key Data Points

Primary metrics and data points about AtriCure.
Current Price: $15.21
Prev Close: $15.05
Open: $15.10
Bid: $15.18
Ask: $15.21
Day's Range: $15.10 - $15.32
52wk Range: $13.44 - $26.88
Volume: 22,213
Avg Vol 208,508
Market Cap: $490.01M
P/E (ttm): -12.86
EPS (ttm): -$1.17
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about AtriCure.
CAPS Rating 3 out of 5
 
52 Outperform
7 Underperform
CAPS All Stars
 
11 Outperform
1 Underperform

How do you think AtriCure will perform against the market?



You pick for AtriCure is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael Carrel, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AtriCure.

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT